Published in Ann Thorac Surg on March 01, 2010
Invited commentary. Ann Thorac Surg (2010) 0.75
A simpler alternative to the Bentall operation using a stentless valve. Ann Thorac Surg (2011) 0.75
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04
Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med (2008) 6.77
Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med (2012) 6.27
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med (2012) 4.47
Submarine canyons: hotspots of benthic biomass and productivity in the deep sea. Proc Biol Sci (2010) 3.98
Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol (2012) 3.29
Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation (2007) 3.05
Man and the last great wilderness: human impact on the deep sea. PLoS One (2011) 2.70
Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol (2012) 2.56
Factors associated with primary graft failure after heart transplantation. Transplantation (2010) 2.38
Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study. J Am Coll Cardiol (2012) 2.33
Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling. Circ Heart Fail (2011) 2.19
World-wide whale worms? A new species of Osedax from the shallow north Atlantic. Proc Biol Sci (2005) 2.18
Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure. Circulation (2012) 2.17
30-day readmissions after coronary artery bypass graft surgery in New York State. JACC Cardiovasc Interv (2011) 2.09
The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv (2012) 2.08
Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation (2006) 1.86
Risk score for predicting long-term mortality after coronary artery bypass graft surgery. Circulation (2012) 1.83
Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation (2011) 1.79
Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation. Circ Heart Fail (2012) 1.79
Biotic and human vulnerability to projected changes in ocean biogeochemistry over the 21st century. PLoS Biol (2013) 1.78
Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg (2004) 1.71
Long-term mortality of coronary artery bypass grafting and bare-metal stenting. Ann Thorac Surg (2011) 1.60
Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stents. Ann Thorac Surg (2013) 1.54
Use of carotid-subclavian arterial bypass and thoracic endovascular aortic repair to minimize cerebral ischemia in total aortic arch reconstruction. J Thorac Cardiovasc Surg (2010) 1.54
Preoperative assessment of high-risk candidates to predict survival after heart transplantation. Circ Heart Fail (2013) 1.53
The New York risk score for in-hospital and 30-day mortality for coronary artery bypass graft surgery. Ann Thorac Surg (2012) 1.51
Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol (2003) 1.50
Contemporary Outcomes of Venoarterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock at a Large Tertiary Care Center. ASAIO J (2015) 1.48
Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann Thorac Surg (2007) 1.47
Open distal anastomosis in aortic root replacement using axillary cannulation and moderate hypothermia. J Thorac Cardiovasc Surg (2009) 1.47
Long-term outcomes with a minimally invasive approach for resection of cardiac masses. Ann Thorac Surg (2010) 1.45
Dynamics of bone turnover markers in patients with heart failure and following haemodynamic improvement through ventricular assist device implantation. Eur J Heart Fail (2012) 1.43
Risk stratification of in-hospital mortality for coronary artery bypass graft surgery. J Am Coll Cardiol (2006) 1.43
Impact of aortic annular size on rate of reoperation for left ventricular outflow tract obstruction after repair of interrupted aortic arch and ventricular septal defect. Ann Thorac Surg (2010) 1.42
Aortic valve replacement for patients with severe aortic stenosis: risk factors and their impact on 30-month mortality. Ann Thorac Surg (2009) 1.42
The relationship between perioperative temperature and adverse outcomes after off-pump coronary artery bypass graft surgery. J Thorac Cardiovasc Surg (2010) 1.42
Totally endoscopic atrial septal defect repair with robotic assistance. Circulation (2003) 1.40
Management of sternal wounds with bilateral pectoralis major myocutaneous advancement flaps in 114 consecutively treated patients: refinements in technique and outcomes analysis. Plast Reconstr Surg (2004) 1.33
Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial. Ann Thorac Surg (2013) 1.33
Use of the Kansas City Cardiomyopathy Questionnaire for monitoring health status in patients with aortic stenosis. Circ Heart Fail (2012) 1.32
The golden age of minimally invasive cardiothoracic surgery: current and future perspectives. Future Cardiol (2011) 1.32
Robotic techniques improve quality of life in patients undergoing atrial septal defect repair. Ann Thorac Surg (2004) 1.29
Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transplant (2010) 1.28
Minimally invasive versus sternotomy approach for mitral valve surgery: a propensity analysis. Ann Thorac Surg (2010) 1.23
High lung allocation score is associated with increased morbidity and mortality following transplantation. Chest (2009) 1.22
Megafaunal communities in rapidly warming fjords along the West Antarctic Peninsula: hotspots of abundance and beta diversity. PLoS One (2013) 1.21
Impella LP 2.5 for left ventricular unloading during venoarterial extracorporeal membrane oxygenation support. J Card Surg (2011) 1.16
Subclavian artery cannulation for venoarterial extracorporeal membrane oxygenation. ASAIO J (2012) 1.16
Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg (2010) 1.16
Comparative composition, diversity and trophic ecology of sediment macrofauna at vents, seeps and organic falls. PLoS One (2012) 1.14
Ligand tuning in asymmetric hydrovinylation of 1,3-dienes: a stereoselective route to either steroid-C20 (S) or -C20 (R) derivatives. J Am Chem Soc (2008) 1.13
Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction. J Heart Lung Transplant (2012) 1.13
Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg (2012) 1.12
Aortic valve and ascending aorta guidelines for management and quality measures. Ann Thorac Surg (2013) 1.11
A minimally invasive approach is more cost-effective than a traditional sternotomy approach for mitral valve surgery. J Thorac Cardiovasc Surg (2011) 1.11
Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors. Ann Thorac Surg (2011) 1.09
Does robotic technology make minimally invasive cardiac surgery too expensive? A hospital cost analysis of robotic and conventional techniques. J Card Surg (2005) 1.07
Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention? J Am Coll Cardiol (2013) 1.06
Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial). Am J Cardiol (2011) 1.05
Relation of preoperative serum albumin levels to survival in patients undergoing left ventricular assist device implantation. Am J Cardiol (2013) 1.04
Comparative effectiveness of minimally invasive versus traditional sternotomy mitral valve surgery in elderly patients. J Thorac Cardiovasc Surg (2012) 1.03
The Southern Ocean ecosystem under multiple climate change stresses--an integrated circumpolar assessment. Glob Chang Biol (2015) 1.03
Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system. J Heart Lung Transplant (2012) 1.02
Preoperative serum albumin levels predict 1-year postoperative survival of patients undergoing heart transplantation. Circ Heart Fail (2013) 1.02
Evolution of cannulation techniques for minimally invasive cardiac surgery: a 10-year journey. Innovations (Phila) (2012) 1.02
Biodiversity of nematode assemblages from the region of the Clarion-Clipperton Fracture Zone, an area of commercial mining interest. BMC Ecol (2003) 1.01
Implementation of echocardiography core laboratory best practices: a case study of the PARTNER I trial. J Am Soc Echocardiogr (2013) 1.01
(R)-3-METHYL-3-PHENYL-1-PENTENE VIA CATALYTIC ASYMMETRIC HYDROVINYLATION. Organic Synth (2008) 1.01
Safe transport of critically ill adult patients on extracorporeal membrane oxygenation support to a regional extracorporeal membrane oxygenation center. ASAIO J (2011) 1.00
Gait speed and dependence in activities of daily living in older adults with severe aortic stenosis. Clin Cardiol (2012) 0.99
Endoscopic computer-enhanced mediastinal mass resection using robotic technology. Heart Surg Forum (2003) 0.98
On the role of bone-eating worms in the degradation of marine vertebrate remains. Proc Biol Sci (2008) 0.98
Quality, not volume, determines outcome of coronary artery bypass surgery in a university-based community hospital network. J Thorac Cardiovasc Surg (2011) 0.97
Usefulness of two-dimensional echocardiographic parameters of the left side of the heart to predict right ventricular failure after left ventricular assist device implantation. Am J Cardiol (2011) 0.97
Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review. J Am Coll Cardiol (2011) 0.97
Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device. J Heart Lung Transplant (2011) 0.96
Aortic valve and ascending aorta guidelines for management and quality measures: executive summary. Ann Thorac Surg (2013) 0.96
A novel protocol of retrograde cerebral perfusion with intermittent pressure augmentation for brain protection. J Thorac Cardiovasc Surg (2005) 0.96
Aortic valve procedures at the time of ventricular assist device placement. Ann Thorac Surg (2011) 0.94
Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients. Circ Heart Fail (2014) 0.93
Del Nido Cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute myocardial infarction: a propensity matched comparison. J Cardiothorac Surg (2014) 0.93
Myocardial protection using del nido cardioplegia solution in adult reoperative aortic valve surgery. J Card Surg (2014) 0.93
Assessment of safety of lactobacillus strains based on resistance to host innate defense mechanisms. Clin Diagn Lab Immunol (2003) 0.92
Species-energy relationships in deep-sea molluscs. Biol Lett (2011) 0.92
Validity and reliability of a novel slow cuff-deflation system for noninvasive blood pressure monitoring in patients with continuous-flow left ventricular assist device. Circ Heart Fail (2013) 0.92
A decade of pediatric mechanical circulatory support before and after cardiac transplantation. J Thorac Cardiovasc Surg (2011) 0.92
Ventricular assist device support as a bridge to heart transplantation in patients with giant cell myocarditis. Eur J Heart Fail (2012) 0.91
Immunologic sensitization in recipients of left ventricular assist devices. J Thorac Cardiovasc Surg (2003) 0.91
Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation. J Heart Lung Transplant (2013) 0.91
Deep hypothermic circulatory arrest for complex cerebral aneurysms: lessons learned. Neurosurgery (2007) 0.91
Facile Pd(II)- and Ni(II)-catalyzed isomerization of terminal alkenes into 2-alkenes. J Org Chem (2009) 0.91